Susquehanna Portfolio Strategies LLC Has $174,000 Stock Position in The Beauty Health Company (NASDAQ:SKIN)

Susquehanna Portfolio Strategies LLC lessened its stake in The Beauty Health Company (NASDAQ:SKIN - Free Report) by 66.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 109,508 shares of the company's stock after selling 215,867 shares during the period. Beauty Health comprises approximately 0.6% of Susquehanna Portfolio Strategies LLC's portfolio, making the stock its 11th largest position. Susquehanna Portfolio Strategies LLC owned 0.09% of Beauty Health worth $174,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in SKIN. Bridgeway Capital Management LLC lifted its position in Beauty Health by 13.6% in the fourth quarter. Bridgeway Capital Management LLC now owns 1,211,600 shares of the company's stock valued at $1,926,000 after acquiring an additional 145,000 shares during the last quarter. Renaissance Technologies LLC purchased a new position in Beauty Health during the fourth quarter worth approximately $64,000. Mirabella Financial Services LLP acquired a new stake in Beauty Health during the 4th quarter valued at $14,292,000. SG Americas Securities LLC grew its holdings in Beauty Health by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 35,290 shares of the company's stock valued at $56,000 after purchasing an additional 9,749 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in Beauty Health by 19.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 114,147 shares of the company's stock worth $182,000 after acquiring an additional 18,400 shares in the last quarter. Institutional investors and hedge funds own 93.26% of the company's stock.

Beauty Health Stock Performance

Shares of Beauty Health stock traded down $0.13 on Wednesday, reaching $1.56. The stock had a trading volume of 371,479 shares, compared to its average volume of 1,053,827. The stock has a market cap of $195.38 million, a P/E ratio of -3.71 and a beta of 0.88. The Beauty Health Company has a fifty-two week low of $0.78 and a fifty-two week high of $2.76. The business's 50-day moving average price is $1.22 and its two-hundred day moving average price is $1.45. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56.

Beauty Health (NASDAQ:SKIN - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.05. The company had revenue of $69.60 million for the quarter, compared to analyst estimates of $63.88 million. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. On average, sell-side analysts forecast that The Beauty Health Company will post -0.25 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group dropped their price target on shares of Beauty Health from $1.50 to $1.25 and set a "hold" rating on the stock in a research report on Monday, May 5th.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.